BACCMEDIUM SIGNALFINANCIAL10-Q

BACC is a newly formed SPAC that completed its IPO and is actively searching for acquisition targets, with $203.7M held in trust and declining operating cash as it pursues business combinations.

This is a typical early-stage SPAC in search mode, having raised substantial capital through its IPO but not yet identifying acquisition targets. The company is burning through its operating cash while conducting due diligence activities, which is expected behavior for SPACs in this phase of their lifecycle.

Comparing 2025-11-12 vs 2025-08-12View on EDGAR →
FINANCIAL ANALYSIS

The company's financial position shows the typical cash burn pattern of an active SPAC, with operating cash declining from $561K to $359K and current liabilities increasing to $1.6M as the company incurs expenses related to its acquisition search. Net income decreased meaningfully to $1.1M, reflecting the costs associated with identifying and evaluating potential business combination targets. The substantial trust account balance of $203.7M remains the key financial asset available for future acquisitions.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
+48.6%
$1.1M$1.6M

Current liabilities surged 48.6% — significant near-term obligations; verify ability to meet short-term debt.

Net Income
P&L
-40.7%
$1.9M$1.1M

Net income declined 40.7% — review whether driven by operations, interest costs, or non-recurring items.

Cash & Equivalents
Balance Sheet
-36.1%
$561K$359K

Cash declined 36.1% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Current Assets
Balance Sheet
-23.3%
$658K$505K

Current assets declined 23.3% — monitor working capital adequacy and short-term liquidity.

LANGUAGE CHANGES
NEW — 2025-11-12
PRIOR — 2025-08-12
ADDED
As of September 30, 2025, the Company had not commenced any operations.
All activity for the period from February 10, 2025 (inception) through September 30, 2025 relates to the Company s formation, the Initial Public Offering (as defined below), and the search for a suitable target to effect the Business Combination.
Liquidity and Capital Resources As of September 30, 2025, the Company had $ 1,045,403 cash and working capital of $ 1,061,429 .
In the opinion of Company management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair statement of the financial position, operating results and cash flows for the periods presented.
The Company had $ 1,045,403 cash and no cash equivalents as of September 30, 2025.
+7 more — sign up free →
REMOVED
Unaudited Condensed Balance Sheet as of June 30, 2025 1 Unaudited Condensed Statement of Operations for the three months ended June 30, 2025 and for the period from February 10, 2025 (Inception) through June 30, 2025 2 Unaudited Condensed Statement of Changes in Shareholders Deficit for the three months ended June 30, 2025 and for the period from February 10, 2025 (Inception) through June 30, 2025 3 Unaudited Condensed Statement of Cash Flows for the period from February 10, 2025 (Inception) through June 30, 2025 4 Notes to Unaudited Condensed Financial Statements 5 Item 2.
The Company has not selected any specific Business Combination target and the Company has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any Business Combination target with respect to an initial Business Combination with the Company.
As of June 30, 2025, the Company had not commenced any operations.
All activity for the period from February 10, 2025 (inception) through June 30, 2025 relates to the Company s formation and the Initial Public Offering (as defined below).
Liquidity and Capital Resources As of June 30, 2025, the Company had $ 1,235,432 cash and working capital of $ 1,269,573 .
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →